CompoAtlas

Confort urinaire masculin

Food supplement declared in France, declaration No 2022-5-1405

Confort urinaire masculin, from EQUILIBRE, is a food supplement declared in France. Status: withdrawn from the market on 1 October 2026. Main ingredients: Cucurbita pepo 150 mg per day, Epilobium angustifolium 150 mg per day, Prunus africana 150 mg per day, Serenoa repens 150 mg per day. 2 rules of use apply to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
EQUILIBRE
Status
Withdrawn from the market on 1 October 2026
Form
Capsule
Daily dose
2 gélules
Directions for use
2 gélules par jour

Declaration 322745, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Cucurbita pepo L.GrainePoudre (de plantes séchées ou broyées)150 mg
Epilobium angustifolium L.Parties aériennesPoudre (de plantes séchées ou broyées)150 mg
Prunus africana (Hook. f.) KalkmanEcorcePoudre (de plantes séchées ou broyées)150 mg
Serenoa repens (W.Bartram) SmallFruitPoudre (de plantes séchées ou broyées)150 mg

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Demander conseil après d'un professionnel de santé

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Prunus africana (Hook. f.) Kalkman
    Read the warning, when it applies and the studies cited

    PYGEUM - PRUNUS AFRICANA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.

    Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 26 June 2026

  • Serenoa repens (W.Bartram) Small
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Confort urinaire masculin: composition and regulation”, https://compoatlas.com/en/supplements/products/322745-confort-urinaire-masculin, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line